Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Jun 28, 2011

Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner

Award Recognizes Entrepreneurial Excellence in Life Sciences Category
Jun 22, 2011

Cepheid Appoints Vice President of Infectious Disease Research & Development
May 18, 2011

Cepheid Appoints LABSCO as US Small Hospital Distributor

Agreement Gives LABSCO Exclusive Rights to Acute Care Hospital Market Below 150 Beds
May 12, 2011

Cepheid to Webcast Upcoming Financial Presentations
Apr 28, 2011

Cepheid to Webcast Upcoming Financial Presentations
Apr 26, 2011

Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain

Menu Expansion Continues with 11th FDA Cleared Test for Use on Cepheid's GeneXpert System
Apr 20, 2011

Cepheid Reports 2011 First Quarter Results

Record Revenue Reflects 28% Growth in Clinical Business
Apr 11, 2011

Cepheid Extends Rapid Molecular Diagnostics' Leadership with FDA Clearance of Xpert Clostridium difficile/Epi

New Test Identifies Epidemic 027 Strain
Apr 6, 2011

Cepheid Schedules 2011 First Quarter Financial Results Announcement and Webcast
Mar 15, 2011

Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors

Show per page

Back to Top